MLXs

At the end of the exercise copies of all non-confidential replies can be requested from our Information Centre, e-mail info@mhra.gsi.gov.uk.

Latest MLXs

• 09 Feb 2010 | Public consultation (MLX 367): Proposals for amendments to the Prescription Only Medicines (Human Use) Order 1997 (the POM Order)
  

  This consultation seeks views on whether to amend the list of Prescription Only Medicines which can be administered parenterally by anyone for the purpose of saving life in an emergency under Article 7 of the POM Order.

• 01 Feb 2010 | Public consultation (MLX 366): Intention to amend the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008 (SI 2008/1692)
  

  MLX 366 seeks your views on how current professional guidance can be expanded to provide additional support for community pharmacists following forthcoming legislative changes and also seeks views on any impact on businesses or equality issues.

• 01 Feb 2010 | Public consultation (MLX 364): The regulation of nicotine containing products (NCPs)
  

  MLX 364 seeks your views on bringing NCPs within the medicines licensing regime.

• 18 Dec 2009 | Public consultation (MLX 365): Measures to strengthen the medicines’ supply chain and reduce the risk from counterfeit medicines
  

  MLX 365 seeks your views on specific proposals designed to strengthen the medicines supply chain in the UK. It follows and builds on responses to ideas set out in an earlier consultation.

• 19 Oct 2009 | Public consultation (MLX 363): MHRA regulatory fees for medicines - proposals for 1 April 2010
  

  MLX 363 sought your views on proposals to change the levels of fees charged by the MHRA for the regulation of medicines, including herbal and homeopathic medicines, and blood establishments and blood banks.

• 28 Aug 2009 | Public consultation (MLX 362): Sale, supply and administration of medicines by dental hygienists and dental therapists under a Patient Group Direction
  

  MLX 362 sought your views on proposals to amend medicines legislation to enable dental hygienists and dental therapists to sell, supply and administer medicines under a Patient Group Direction (PGD).

• 14 Aug 2009 | Public consultation (MLX 358): The European Commission proposals on information to patients for prescription medicines
  

  MLX 358 sought your views on a European Commission proposal that would allow the pharmaceutical industry to provide information to the public on prescription only medicines, as advertising of these medicines to the public is not allowed.

• 08 Jul 2009 | Public consultation (MLX 361): UK proposals on charging fees for variations to medicines marketing authorisations
  

  MLX 361 seeks your views on proposals to amend the current UK fees legislation (Statutory Instrument (SI) 2009/389) relating to variations to Marketing Authorisations (MAs) to include new fees for MA variations in order to comply with the new European Regulation.

• 03 Jul 2009 | Public consultation (MLX 360): Latent UK marketing authorisation (MA) applications
  

  MLX 360 seeks your views on proposals to clarify and amend the current decision making procedure to refuse an application for a UK marketing authorisation (MA).

• 08 Jun 2009 | Public consultation (MLX 359): Consultation on the European Commission's legislative proposal to strengthen patient safety (‘pharmacovigilance’)
  

  This consultation invites comments from stakeholders on the European Commission's legislative proposals to strengthen and rationalise the EU pharmacovigilance systems.